AccueilVeille ScientifiqueSafety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled study

The Lancet Infectious Diseases • 2021.04.02

Cohen D., Atsmon J., Artaud C.,